Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria.

Authors:
Ochi H; Hiraoka A; Hirooka M; Koizumi Y; Amano M and 10 more

Journal:
J Gastroenterol

Publication Year: 2020

DOI:
10.1007/s00535-020-01747-y

PMCID:
PMC7819935

PMID:
33278003

Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest All authors have no conflicts of interest to disclose."

Evidence found in paper:

"The authors would like to thank all of the patients and their families, as well as the staff of the three participating institutions. This study did not receive financial support."

Evidence found in paper:

"This study was approved by the institutional review board and ethics committee of Matsuyama Red Cross Hospital (No. 751). This study was registered with the UMIN Clinical Trials Registry as UMIN000038109. All medications were open-label drugs. All parts of the research were conducted in accordance with the principles in the Declaration of Helsinki."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025